Are elevated serum haemolysis markers a harbinger of adverse events in HeartMate II patients?
Zayat R, Shoaib M, Khattab MA, Ahmad U, Goetzenich A, Stoppe C, Foldenauer AC, Moza A, Schnoering H, Autschbach R, Tewarie L.
Zayat R, et al. Among authors: foldenauer ac.
Interact Cardiovasc Thorac Surg. 2018 Jul 1;27(1):5-12. doi: 10.1093/icvts/ivy027.
Interact Cardiovasc Thorac Surg. 2018.
PMID: 29444250